SARS-CoV-2 oral tablet vaccination induces neutralizing mucosal IgA in a phase 1 open label trial

Susan Johnson, Clarissa I Martinez, Clara B Jegede, Samanta Gutierrez, Mario Cortese, C Josefina Martinez, Shaily J Garg, Nadine Peinovich, Emery G Dora, Sean N Tucker
doi: https://doi.org/10.1101/2022.07.16.22277601

Data Availability

All data produced in the present work are contained in the manuscript

Back to top
Posted July 19, 2022.
Download PDF
Data/Code
Email
SARS-CoV-2 oral tablet vaccination induces neutralizing mucosal IgA in a phase 1 open label trial
Susan Johnson, Clarissa I Martinez, Clara B Jegede, Samanta Gutierrez, Mario Cortese, C Josefina Martinez, Shaily J Garg, Nadine Peinovich, Emery G Dora, Sean N Tucker
medRxiv 2022.07.16.22277601; doi: https://doi.org/10.1101/2022.07.16.22277601
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area